The prevention of the trauma-related venous thromboembolism by anticoagulation.

The prevention of the trauma-related venous thromboembolism by anticoagulation. - The prevention of the trauma-related venous thromboembolism by anticoagulation.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022444

Enrollment

100

Registered

2016-05-31

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe trauma

Interventions

We perform intravenous administration of unfractionated heparin(10000 unit/day) for 14 days.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Trauma patients with 5 or more points of RAP score.

Exclusion criteria

Exclusion criteria: The patients that hemostasis is not obtained. The patients with serious liver dysfunction or renal dysfunction. The patients with a history of Heparin-induced thrombocytopenia (HIT). The patients of the drug irritable diathesis such as allergies. The patients who may be pregnant and breast feeding. The patients whom a primary investigator judged to be inadequate for the study.

Design outcomes

Primary

Measure	Time frame
Incidence of venous thromboembolism(VTE) during the hospitalization	—

Secondary

Measure	Time frame
Incidence of hemorrhagic adverse event Hospitalization Medical expenses	—

Countries

Japan

Contacts

Public ContactKeita Iyama

Nagasaki University Hospital Emergency Medical Center

k-iyama@nagasaki-u.ac.jp095-819-7200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026